March 11, 2005 -- The U.S. Food and Drug Administration (FDA) has warned healthcare professionals and patients via public health advisory of the potential cancer risk associated with use of ...

Astellas, an American a Japanese drug company, is suing a medical journal in Paris in part because it used a cartoon of a man in a silly hat to criticize one of its drugs, the eczma skin cream ...

Two relatively new and very popular prescription creams used to treat eczema (search) in children and adults may soon carry a "black box" warning — indicating the drugs represent a cancer risk for ...

Perrigo announced the availability of Tacrolimus Ointment, the generic version of Astellas’ Protopic Ointment. Protopic is an immunomodulator that is indicated as second-line therapy for short-term ...

Two eczema creams — Novartis AG’s Elidel and Fujisawa Healthcare, Inc.’s Protopic, must carry a strong warning of cancer risk, the Food and Drug Administration said Thursday. Subscribe to read this ...

Glenmark has received permission from the Food and Drug Administration for Tacrolimus Ointment, 0.03%, the generic of Leo Pharma's Protopic. Protopic Ointment, both 0.03% and 0.1% for adults, and only ...

Jan. 19, 2006 — The US Food and Drug Administration (FDA) has approved revisions to the safety labeling for 1% pimecrolimus cream ( Elidel, made by Novartis Pharmaceuticals Corporation) and tacrolimus ...

ROCKVILLE, Md., Jan. 20 - The FDA said black box warnings about the possible risks of skin cancer and lymphoma have been added to the labels of Elidel Cream (pimecrolimus) and Protopic Ointment ...

WASHINGTON – The labels on two prescription creams to treat eczema will have to bear "black box" warnings of possible cancer risks. The Food and Drug Administration action Thursday follows an agency ...

Protopic, the topical formulation of Astellas’ tacrolimus, has been launched in Europe for a new indication – as maintenance treatment to prevent flares and prolong flare-free intervals in adults and ...

The labels on two prescription creams to treat eczema will have to bear “black box” warnings of possible cancer risks. Subscribe to read this story ad-free Get unlimited access to ad-free articles and ...